WP
Therapeutic Areas
Anteris Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DurAVR™ THV System | Severe Aortic Stenosis (Symptomatic) | Early Feasibility Study |
Leadership Team at Anteris Technologies
DC
Dr. Christopher Meduri, MD, MPH
Chief Medical Officer
FR
Felix Roosen
Chief Operating Officer
AM
Annie Miller
Chief Financial Officer
JW
John W. Cumming
Non-Executive Chairman
DA
Dr. Andrew Holden, MBChB, FRANZCR, EBIR
Non-Executive Director
MA
Mark A. Meller
Non-Executive Director